ArticleCureus2024
New Onset of Neuro-Sjögren's Syndrome Nine Months After the Third COVID-19 Vaccine Dose: A Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Review
- Real-World Safety and Efficacy of Biosimilar Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer: A Prospective Single-Institution Study From India.International journal of breast cancer · 2026Article
- Sjögren's Syndrome with Sensory Neuronopathy and Polyradiculoneuropathy.Internal medicine (Tokyo, Japan) · 2025Article
- Regulating Immune Responses Induced by PEGylated Messenger RNA-Lipid Nanoparticle Vaccine.Vaccines · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sjögren's syndrome (SS) is an autoimmune chronic inflammatory disease causing peripheral nerve system and central nervous system issues. It results from lymphocytic infiltrates in exocrine glands, coexists with rheumatoid arthritis, and manifests independently. The COVID-19 vaccine has been linked to increased autoimmune diseases and rheumatological flare-ups, possibly due to its use of adjuvants and molecular mimicry, particularly those containing aluminum. Additionally, SS-like manifestations have been reported after the infection or vaccination, potentially leading to long-term salivary secretory dysfunction. Multiple studies have suggested the presence of a special relationship between COVID-19 vaccination/infection and the emergence of autoimmune syndromes as a negative side effect of the vaccine or direct complication from infection. The time frame for the appearance of the symptoms after vaccination or disease is not well established. Some studies suggested increased risk shortly after vaccination, while others suggested a long-term association. In this case, report, and review article, we discuss the presence of a possible association with the emergence of neuro-SS in a young lady nine months after she received her third dose of COVID-19 vaccination. Furthermore, we reviewed studies highlighting the special link and relationship between the COVID-19 vaccine/infection and SS
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.